Companies
GeneFrontier
reconstituted system of 36 enzymes — protein screening free of bacterial LPS.
- Country
- Japan
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| foundries-design | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Headcount | 14 employees | purefrex.genefrontier.com |
| Headcount | 13 employees | mono.ipros.com |
| Headquarters | Kashiwa, Chiba, Japan | purefrex.genefrontier.com · genefrontier.com |
| Revenue | 163.492 million yen in net profit (as of 2026-03-31) | catr.jp |
| Revenue | -0.137 million yen in net profit (as of 2021-03-31) | catr.jp |
| Capacity | scalable from microliters to liters medium confidence | purefrex.genefrontier.com |
Independent sources: catr.jp · mono.ipros.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cell-free systems & cell-free bioproduction | foundries-design | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.